Biologics News

Although there is a wide array of therapies for patients with rheumatoid arthritis, the choice of when and how aggressively to employ them can sometimes conflict with established guidelines, according to a presenter.

Platelet-rich plasma injections did not show any clinical or functional improvement in the recovery of nonoperatively treated acute Achilles tendon ruptures, according to published results.

Platelet-rich plasma combined with physical therapy for hamstring injury did not yield significant reductions in time to return to play or reinjury rates compared with no treatment or physical therapy alone, according to a study.

Patients with knee osteoarthritis treated with platelet-rich plasma injections may have improved clinical outcomes compared with patients who received hyaluronic acid injections, according to published results.

At the end of 2017, with the demand for the use of biologics in orthopedics outstripping the science as well as the safety and efficacy information available, leaders of the Arthroscopy Association of North American, the American Orthopaedic Society for Sports Medicine and the International Cartilage Regeneration and Joint Preservation Society formed the Biologic Association to provide high-level evidence to physicians and patients and to advance this treatment.

Researchers observed significant improvement in pain and function among patients with knee osteoarthritis who received a single injection of amniotic suspension allograft vs. patients who received a control injection of hyaluronic acid or saline.

Published results showed use of uncultured, unmodified, autologous adipose-derived regenerative cells may be safe and may improve shoulder function without adverse effects in patients with symptomatic, partial-thickness rotator cuff tears.

Patients in the pre-collapse stages of post-traumatic osteonecrosis of the femoral head may receive safe and effective treatment with platelet-rich plasma-incorporated autologous granular bone grafting, according to published results.

The American Academy of Orthopaedic Surgeons announced it has canceled its annual meeting scheduled for March 24-28, 2020, at the Orange County Convention Center in Orlando due to concerns surrounding the novel coronavirus.

Patients who received platelet-rich plasma during surgical treatment of carpal tunnel syndrome regained hand grip strength earlier than patients who received placebo, according to published results.